These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pricing of prescription drugs and its impact on physicians' choice behavior. Miao-Sheng C; Yu-Ti S Health Care Manag Sci; 2008 Sep; 11(3):288-95. PubMed ID: 18826006 [TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical promotion: don't throw the baby out with the bathwater. Dubois RW Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-96-103. PubMed ID: 14527238 [TBL] [Abstract][Full Text] [Related]
25. An intellectual virtue "vaccination" for physician-pharmaceutical industry interactions. Ahmadi Nasab Emran S Acad Med; 2015 Jan; 90(1):30-2. PubMed ID: 25319170 [TBL] [Abstract][Full Text] [Related]
26. Experts' agency problems: evidence from the prescription drug market in Japan. Iizuka T Rand J Econ; 2007; 38(3):844-62. PubMed ID: 18478669 [TBL] [Abstract][Full Text] [Related]
27. US drug marketing: how does promotion correspond with health value? Greenway T; Ross JS BMJ; 2017 May; 357():j1855. PubMed ID: 28465309 [No Abstract] [Full Text] [Related]
28. Factors Influencing Prescribing Decisions of Physicians: A Review. Davari M; Khorasani E; Tigabu BM Ethiop J Health Sci; 2018 Nov; 28(6):795-804. PubMed ID: 30607097 [TBL] [Abstract][Full Text] [Related]
29. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence. Datta A; Dave D Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065 [TBL] [Abstract][Full Text] [Related]
30. Medicalization, markets and consumers. Conrad P; Leiter V J Health Soc Behav; 2004; 45 Suppl():158-76. PubMed ID: 15779472 [TBL] [Abstract][Full Text] [Related]
31. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018. Hadland SE; Cerdá M; Earlywine JJ; Krieger MS; Anderson TS; Marshall BDL JAMA Pediatr; 2020 Apr; 174(4):385-387. PubMed ID: 31961384 [TBL] [Abstract][Full Text] [Related]
32. Drug promotional practices in Mumbai: a qualitative study. Roy N; Madhiwalla N; Pai SA Indian J Med Ethics; 2007; 4(2):57-61. PubMed ID: 18630221 [TBL] [Abstract][Full Text] [Related]
33. Rationalising prescribing: Evidence, marketing and practice-relevant knowledge. Wadmann S; Bang LE Soc Sci Med; 2015 Jun; 135():109-16. PubMed ID: 25965891 [TBL] [Abstract][Full Text] [Related]
34. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Wilkes MS; Bell RA; Kravitz RL Health Aff (Millwood); 2000; 19(2):110-28. PubMed ID: 10718026 [TBL] [Abstract][Full Text] [Related]
35. Influence of pharmaceutical marketing on prescription practices of physicians. Narendran R; Narendranathan M J Indian Med Assoc; 2013 Jan; 111(1):47-50. PubMed ID: 24000508 [TBL] [Abstract][Full Text] [Related]
36. Prescription of fixed dose combination drugs for diarrhoea. Chakrabarti A Indian J Med Ethics; 2007; 4(4):165-7. PubMed ID: 18630234 [TBL] [Abstract][Full Text] [Related]
37. [Are medical students influenced by the promotion of the pharmaceutical industry?]. Giustetto G Recenti Prog Med; 2014 Dec; 105(12):445-7. PubMed ID: 25533229 [TBL] [Abstract][Full Text] [Related]
38. Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium. Cleymans S; Morrens M; Bervoets C J Med Ethics; 2017 Jun; 43(6):359-363. PubMed ID: 27895084 [TBL] [Abstract][Full Text] [Related]
39. Prescriber profiling. Kirk SM Ann Intern Med; 2008 Jan; 148(1):82. PubMed ID: 18166766 [No Abstract] [Full Text] [Related]